CarboplatinEtoposideAntineoplastic Combined Chemotherapy ProtocolsPaclitaxelCisplatinIfosfamideDrug Administration ScheduleAntineoplastic Agents, PhytogenicLung NeoplasmsAntineoplastic AgentsOvarian NeoplasmsCarcinoma, Small CellCombined Modality TherapyThrombocytopeniaPlatinumTreatment OutcomeInfusions, IntravenousCarcinoma, Non-Small-Cell LungCyclophosphamideLeukopeniaDoxorubicinDisease-Free SurvivalVincristineTopoisomerase II InhibitorsArea Under CurveHematologic DiseasesNeutropeniaOrganoplatinum CompoundsGerminomaDose-Response Relationship, DrugSurvival AnalysisSurvival RateThiotepaRetinal NeoplasmsTesticular NeoplasmsTopotecanMaximum Tolerated DoseDrug EvaluationNeoplasm StagingFallopian Tube NeoplasmsDNA Topoisomerases, Type IIRetinoblastomaNeoplasms, Germ Cell and EmbryonalPodophyllotoxinDeoxycytidineRemission InductionDrug Resistance, NeoplasmVinblastineSeminomaNeoplasmsTransplantation, AutologousSalvage TherapyBleomycinAmifostineNeoplasm Recurrence, LocalTeniposideAmsacrineMesnaPeritoneal NeoplasmsCamptothecinDrug HypersensitivityAlopeciaTaxoidsCytarabineNauseaMelphalanMitoxantroneDrug SynergismBone Marrow DiseasesIsocoumarinsAdministration, OralDrug Screening Assays, AntitumorHematopoietic Stem Cell TransplantationApoptosisCarcinomaNeoplasms, Unknown PrimaryRetroperitoneal NeoplasmsFeasibility StudiesGranulocyte Colony-Stimulating FactorVomitingGuanineBrain NeoplasmsSmall Cell Lung CarcinomaCell Line, TumorTumor Cells, CulturedGlutamatesDNA DamageMediastinal NeoplasmsChemotherapy, AdjuvantAntibodies, Monoclonal, HumanizedCell SurvivalPrognosisNeoplasm MetastasisNucleic Acid Synthesis InhibitorsTopoisomerase InhibitorsAntineoplastic Agents, AlkylatingHodgkin DiseaseNeoplasms, Glandular and EpithelialAdenocarcinomaDrug Resistance